Mediation of Cellular Immunity in Cancer by immune Modifiers. Progress in Cancer Research and Therapy, Vol. 19 by Moore, M.
Br. J. Cancer (I1982) 46, 307
Book Reviews
Pulmonary Masses, Cysts and Cavities:
A Radiologic Approach. 1. M. FREUND-
LICH (1981). London: Year-Book Medical
Publishers. 223 pp. £26.0() net.
'lhiis book i; divided into ,5 sections. includ-
inig the introduction. In the introduction the
terms used in the text are defined. r'l'e second
section deals with the radiological manifesta-
tions of disease processes. Classification of
these disease processes is into congenital.
inflammatory. neoplastic. traumatic aind
thrombo-embolic groups. and within each
group there are separate sections describing
the radiological appearances of masses, cysts
and cavities. The text, is; clear a,nd concise
and most of the radiographs are of good
quality. Some of the inflammatory conditionis
discussed are not encouintered in the U.K.
Section 3 deals with the complications of
cysts and cavities, and again the text is clear
and concise. Section 4 essentially deals witlh
the differential diagnosis of benign and malig-
nant lesions, with two other short sections.
one describing the distinction between a cyst
and a cavity, the other discussing the
differential diagnosis of a bronchopleural
fistula and an abscess. lThe problem. which
taxes all radiologists, whether a lesion in the
lungs is benign or malignant, is discussed
logicall,. and the criteria of malignancy and
benignitiy aie listed. T'he role of CT is dis-
cussed. My only criticism of this section is
the inclusioin of primary lymphonma of the
lung as a lenign entity. Section 5 consists of
10 cases for self assessment.
'Fhe book is easily readable. TI'Ie text is
well written and concise, and I would recom-
mnend this book to radiologists in training.
and also as a handy reference hook for use
in the radiological department.
R. J1. J0T1NSO-N
Mediation of Cellular Immunity in Can-
cer by immune Modifiers. Progress in
Cancer Research and Therapy, Vol. 19.
Eds. M. A. CHIRIGOS, M. MITCHELL
M. J. MASTRANG(ELO & M. KRIM (1981).
NewN, York: Raven Press. 275 pp.
'I'lhis volumne comprises a series ofcontril)u-
tionxs made to a workshop on the effects of
Biological Responise Modifiers oni Cell-media-
ted Immunity, lheld under the auspices of the
National Cancer Institute of the United
States of America. The statement in the
Preface that it contains "a considerable
amount of new and pertinent information
concerning the clharacteristics of cytotoxicity
against a variety of human tumours.
may b)e appropriate for relative newcomers to
the field, but specialists and other seasoned
observers of immunological phenonmena in
cancel wsill quickly perceive a degree of
recapitulation which has regrettably become
commonplace in this field. The former group
will be moderately well served byr a book
which, w-hile falling short of being compre-
hensive. contains some useful material (linked
to a good index) on immunomodulation of
macrophages and NK cells, between which
the book is roughly equally divided, by
numerous prominent names in these fields.
fn the section on macrophage activationi
and suppressioin, two contributions call for
special mention: a paper by Oppenheim et al.
devoted to a description of the means where-
ly macrophage-lymphocyte interactions lead
to the generation of cytokines such as IL-1.
CSF and IFN, endogenous signals which, by
activating lymphocytes andpromoting macro-
phage la and FcR expression. enhance the
capabilitv of these cells to maintain hoost
integrity. T'he afferent limb of the immune
response thus offers a multiplicity of oppor-
tunities for modif,ving the biological response.
A second notable paper in this section is that
of Meltzer et al.. which envisages the develop-
ment of macrophage cytotoxicity as analog-
ous to b)lood coagulation or complement-
mediated haemolysis. in so far as the final
events are determined by multifarious pre-
ceding reactions, initially in response to
priming and trigger signals in lymphokine
supernatanits, via thie production of non-
cytotoxic intermediates (the principal sub-
ject of the article) according to a defined
sequence. Other chapters of interest in the
section on macrophages deal variously with
the interrelationship between tumoricidal
activity. NK augmentation, delayed-type
hypersensitivity and immune modifiers
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(involving arachidonic acid metabolism) which
regulate macrophage-mediated cytotoxicity
(Schultz) and wtith the effects of irradiation
and cis-diammine dichloroplatinum on spon-
taneous monocyte-nmediated cvtotoxicity
(Muchmore).
In the second section of the book, largely
devoted to modulation of NK activity, the
tracks are indeed well-worn, for this is surely
a topic which has suffered from literarv over-
exposure. Inevitably, the critical experiments
establishing an unequivocal role for NK cells
in surveillance against malignant disease
remain elusive. This is not surprising. since a
plethora of immune and non-immune factors
must be involved in the exercise of host
restraint. Familiarity, however, does not
breed contempt, for there are useful, if repeti-
tive, chapters on enhancement of CTL and
NK activities (Zarling), on natural killer
clones (Dennert) and on in vitro generation
of NK-like activity (Trinchieri), as well as on
enhancement of human NK activity in vivo
by IFN (Einhorn). The book culminates in a
skilful and prudent review of the state of the
art from Herberman.
Having said this, the positive features of
the book are probably insufficient for com-
pulsory purchase by the specialist, for whom
it would have decidedly limited utility. There
is, however, a case for having a series of
articles addressing closely related themes
between the same covers, provided the general
level of scientific acceptability is high, which
this is. Readers will look in vain for data on
IL-2, for such has been the rapidity of
development in this field that the workshop
antedated the impact of IL-2 on current
thinking about the interaction between
adaptive and natural immunity.
M. MOORE
Controversies in Oncology. Ed. P. H.
WIERNIK (1982). Chichester: John Wilev
& Sons. 415 pp. £28.70 net.
This book provides an interesting approach
to the understanding of important controver-
sies in oncology. Each controversial issue is
debated in two chapters by different authors.
each setting out one side of the argument.
The result is an extremely interesting and
easily readable text. The subjects for dis-
cussion have been N-ell selected and cover
imany of the major controversies in haemato-
logic malignancies, adjuvant therapy of solid
tumours, supportive care and certain innova-
tive forms of therapy. Subjects include
combined modality therapy in early-stage
Hodgkin's disease, intensive treatment of
low-grade malignant lymphoma, androgen
therapy in haematologic malignancies, adju-
vant therapy for osteosarcoma and breast
cancer, and tlhe role of protected environ-
ments and granulocyte transfusions for
immunosuppressed patients. Other important
issues which are discussed include the prob-
lems of single-institution studies vs those
of mnulticentre collaborative-group studies.
leading experts on these controversial issues
have been chosen carefully and the clinical
oncologist w-ill find the approach an interest-
ing and informative one.
D. CROWTHER
Cancer-Principles and Practice of
Oncology. V. DE ATITA, JR, S. HELLMAN &
S. A. ROSENBERG (1982). Philadelphia:
Lippincott. 1926 pp. £75.00 net.
This is the most comprehensive textbook
on the principles and practice of oncology
ever w,ritten. Almost all the 104 contributors
are from the U.S.A., but recognized leading
authorities, experts in the principal modalities
of treatment (surgery, radiotherapy, chemo-
therapy) have been Mwell clhosen. Although
this is a textbook for the clinical oncologist,
4 of the 49 clhapters are devoted to relevant
cancer biology, and these make important
contributions. Chapters on the principles of
surgery, radiotherapy, chemotherapy, psy-
chosociology and the design of clinical trials
then follow. The bulk of the text is devoted
to chapters dealing with the natural history,
pathology and treatment of different cancers
bv site. The aim has been to present the
reader with a balanced view of management
problems in treating patients with cancer,
and in this the authors have largely succeeded.
This is an essential textbook for all medical
libraries and an important reference book for
all those studying clinical oncology.
D. CROWATHER
Suppressor Cells in Human Cancer:
Immunology Series Volume 14. Ed.
J. S. GOODWIN (1981). New York: Marcel
Dekker. 363 pp.
Over the last 5 years a vast amount ofMwork
has been published on celluiar mechanisms